Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

PaperCitations, authors & open-access status

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 771 citations, 2021 year and hybrid oa status.

771
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

John Ramage
Author
The Lancet Oncology
Journal
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
Gallbladder and Bile Duct Disorders
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
470M+ articles · free account